Feds Take Action Against Tylenol-Maker McNeil

The U.S. Food and Drug Administration and the Justice Department took action against McNeil-PPC today, filing a proposed consent decree for failing to follow good manufacturing practices in the two-year wake of massive recalls of popular over-the-counter drugs including Tylenol, Rolaids, Benadryl and Motrin, the agencies said.

McNeil, a subsidiary of Johnson & Johnson, has been plagued with recall after recall for manufacturing problems, labeling issues and foul odors in its products -- some of which have sickened consumers.

In a statement sent to Consumer Ally, McNeil said it has already been putting remediation programs in place in a plan it gave to the FDA in July 2010.

"McNeil believes that the terms of the Consent Decree recognize the progress made in remediation efforts to date, and are consistent with the commitments the company has made," McNeil said in the statement. The consent decree was agreed to by McNeil and governs the operations at three plants.